Delivery Order SPE2DB22D1103-SPE2DB24FTPU5

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The order, valued at $23,561.09, is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication, to support military healthcare programs. Amerisourcebergen, a for-profit organization, has a significant track record of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,360.46, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of a specific pharmaceutical product, Aimovig 140 mg/ml autoinjector, with a ceiling value of $1,264.14 and a completion date of February 27, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. As a key...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a $1,070.94 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, an established pharmaceutical distributor. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the agency to efficiently procure a wide range of essential pharmaceutical products and medical supplies for the Department of Defense worldwide. The current...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a firm fixed price of $1,526.34 and a completion date of June 12, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,395.48 firm fixed-price delivery order is for AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $5,706.48, is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication, with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at...
This federal contract award is for a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply AIMOVIG 140 MG/ML AUTOINJECTORML. The contract, valued at $2,353.16, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on October 17, 2024, with an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $22,475.08 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4565753803 ! AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of September 11, 2024 and is not a set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract with the DLA Troop Support Medical valued up to $999,999,999...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTPU5
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The $1,357.86 order is for the drug product AIMOVIG 140 MG/ML AUTOINJECTORML. This order is not set aside and has a firm fixed price. The place of performance is Conshohocken, PA. Amerisourcebergen has been a significant supplier of pharmaceutical and medical products to various federal agencies, including the DLA, through multiple IDCs and other contract vehicles to support the healthcare needs of military personnel, veterans, and other government beneficiaries.

Generated 11/6/24, 9:30 AM